4-7042618-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153376.3(CCDC96):c.321G>T(p.Glu107Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,352,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153376.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC96 | NM_153376.3 | c.321G>T | p.Glu107Asp | missense_variant | 1/1 | ENST00000310085.6 | NP_699207.1 | |
LOC100129931 | NR_033828.1 | n.696+2362G>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC96 | ENST00000310085.6 | c.321G>T | p.Glu107Asp | missense_variant | 1/1 | 6 | NM_153376.3 | ENSP00000309285.4 | ||
TADA2B | ENST00000506692.1 | c.-7+532C>A | intron_variant | 2 | ENSP00000422398.1 | |||||
ENSG00000245748 | ENST00000500031.1 | n.696+2362G>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000681 AC: 8AN: 117406Hom.: 0 AF XY: 0.000123 AC XY: 8AN XY: 64942
GnomAD4 exome AF: 0.0000185 AC: 25AN: 1352642Hom.: 0 Cov.: 29 AF XY: 0.0000301 AC XY: 20AN XY: 664474
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2024 | The c.321G>T (p.E107D) alteration is located in exon 1 (coding exon 1) of the CCDC96 gene. This alteration results from a G to T substitution at nucleotide position 321, causing the glutamic acid (E) at amino acid position 107 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at